Hair Follicle Neogenesis: Can New Follicles Be Grown?

Hair follicle neogenesis means creating entirely new follicles, rather than restoring or relocating ones that already exist. Researchers are investigating ways to encourage follicle growth, but new lab-grown follicles are not currently available as a clinical treatment. Hair transplant surgery moves a patient’s existing follicles from one area of the scalp to another; it does not create new ones (ISHRS patient guide).

Neogenesis is different from regeneration

The terms neogenesis and regeneration are sometimes used interchangeably in promotional material, but they describe different goals. Neogenesis refers to forming a follicle anew. Regeneration is a broader term that can mean improving the activity of an existing follicle or supporting the hair-growth environment. A treatment that increases hair density or thickness does not, by itself, prove that new follicles have formed.

That distinction matters in pattern hair loss. Follicles can gradually miniaturize, producing finer, shorter hairs. Research reviews describe changes in follicle signaling in androgenetic alopecia, including effects involving dermal papilla cells and Wnt-beta-catenin signaling (review by Tosti and colleagues). Supporting a miniaturized follicle and building a completely new, functional follicle are not the same biological task.

Why dermal papilla cells matter

A hair follicle is not just a strand-producing opening in the skin. It is a small, organized structure whose cells communicate with one another through growth signals. Dermal papilla (DP) cells sit at the base of the follicle and help direct hair growth and regulate the hair cycle. They have stem-cell-like characteristics, but that does not mean that a DP-cell injection automatically creates a new follicle.

Hair follicle stem cells (HFSCs) and hair progenitor cells also have different roles. In pattern hair loss, HFSCs may remain present while progenitor-cell activity is reduced; altered androgen signaling can affect DP-cell signals and inhibit canonical Wnt-beta-catenin activity (Tosti and colleagues’ review). This helps explain why researchers study cell signals and supporting cells—but translating those findings into reliable, newly formed follicles remains a separate challenge.

What wound-induced research is exploring

Wound-induced follicle neogenesis is a research idea about whether signals associated with skin injury and healing might prompt new follicles to form. It is not an established way to regrow hair in patients. Reviews of follicle regeneration describe the broader scientific challenge: a lab-grown follicle would need to develop into a functional structure, cycle through growth phases, connect with surrounding tissue, receive a blood supply, and produce appropriately pigmented hair (follicle regeneration review).

Those requirements help explain why “hair cloning” or “new follicle creation” claims should be assessed carefully. A promising cell signal, an increase in visible hair, and a fully formed follicle that can keep cycling are different outcomes. At present, there is no established surgical procedure that creates new lab-grown follicles and transplants them (FDA information on regenerative medicine).

What current regenerative treatments can and cannot show

Investigational approaches include cell transplantation or micrografts, conditioned media, and exosomes. A 2023 systematic review summarized 15 studies involving 653 participants and several different cell-based methods. The studies reported increased hair density, but the authors noted limitations including small samples, varied protocols, and short follow-up (systematic review in Cells). These findings are preliminary; they do not establish that the treatments create new follicles.

Platelet-rich plasma (PRP) is another treatment sometimes discussed alongside regenerative procedures, but it is not the same as follicle neogenesis. In a 2020 systematic review of 12 PRP studies in androgenetic alopecia, 10 reported a positive effect, while six reported statistically significant improvement in objective measures; two found no significant improvement. The review also noted mild side effects such as temporary pain or itching (PRP systematic review). Results from these studies should not be treated as a guarantee for an individual patient.

No stem-cell or regenerative product is FDA-approved for hair loss, and evidence and protocols vary. Exosomes in particular are not FDA-approved for hair loss or any other condition, and available human evidence remains preliminary (American Hair Loss Association information on exosomes). When you speak with a Hair Transplant Clinic, ask whether a proposed treatment aims to support existing follicles or claims to create new ones, what evidence supports that specific method, and what uncertainties remain. Hair Transplant Clinics may use similar-sounding terms for different procedures, so ask the provider to explain exactly what is done and what outcome is being measured.

Frequently Asked Questions

Can a hair transplant create new follicles?

No. FUE and FUT surgery relocate a patient’s existing follicles; they do not generate new ones (ISHRS patient guide). A transplant may redistribute hair to improve coverage, but it cannot increase the total number of follicles available from the donor area.

Are stem-cell hair treatments proven to grow new follicles?

No established treatment has been shown to create transplantable, lab-grown follicles in routine clinical care. Studies of cell-based approaches are investigating possible effects on hair growth, but varied methods and limited follow-up make it important to distinguish early findings from proven neogenesis (systematic review in Cells).

What should I ask about a “new follicle” claim?

Ask what the treatment physically involves, whether the goal is to support existing follicles or form new ones, and what published human evidence supports the claim. You can also ask about regulatory status and risks; FDA registration of a facility or an investigational application should not be confused with FDA approval (FDA patient information).

For now, follicle neogenesis remains a research goal rather than an available hair-restoration procedure. Understanding the difference between new follicle formation and support for existing follicles can help you evaluate claims and have a clearer discussion with a qualified clinician.